"The approval by the FDA is an important milestone for Genzyme, our inventors and the university," Ken Nisbet, associate vice president for research at the U-M Tech Transfer, said in a statement.
Jeremy Allen | jallen42@mlive.com, Kalamazoo Gazette
Thu, 08/21/2014 - 11:12am
"The approval by the FDA is an important milestone for Genzyme, our inventors and the university," Ken Nisbet, associate vice president for research at the U-M Tech Transfer, said in a statement.